These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37237299)

  • 1. CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells.
    Xie J; Lan T; Zheng DL; Ding LC; Lu YG
    BMC Oral Health; 2023 May; 23(1):329. PubMed ID: 37237299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPT1 Promotes Growth and Inhibits Ferroptosis of Oral Squamous Cell Carcinoma Cells.
    Luo Q; Hu S; Tang Y; Yang D; Chen Q
    Curr Cancer Drug Targets; 2024; 24(10):1047-1060. PubMed ID: 38299399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1.
    Wen Z; Zhang Y; Gao B; Chen X
    J Gene Med; 2024 Feb; 26(2):e3669. PubMed ID: 38380717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing CK19 regulates ferroptosis by affecting the expression of GPX4 and ACSL4 in oral squamous cell carcinoma in vivo and in vitro.
    Rao Y; Li J; Shi L; Chen X; Hu Y; Mao Y; Zhang X; Liu X
    Sci Rep; 2024 Jul; 14(1):15968. PubMed ID: 38987531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFE2L1 restrains ferroptosis by transcriptionally regulating HJURP and participates in the progress of oral squamous cell carcinoma.
    Zhang M; Wang Z; Yang G; Han L; Wang X
    J Bioenerg Biomembr; 2023 Dec; 55(6):467-478. PubMed ID: 37848756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.
    Xu D; Gu M; Liu HL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):641-648. PubMed ID: 30720172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 8. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDH4 suppresses the progression of salivary adenoid cystic carcinoma via E-cadherin co-expression.
    Xie J; Feng Y; Lin T; Huang XY; Gan RH; Zhao Y; Su BH; Ding LC; She L; Chen J; Lin LS; Lin X; Zheng DL; Lu YG
    Oncotarget; 2016 Dec; 7(50):82961-82971. PubMed ID: 27783992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1.
    Li K; Zhou Z; Li J; Xiang R
    Technol Cancer Res Treat; 2020; 19():1533033820959404. PubMed ID: 33327874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
    Zhang XJ; Jin Y; Song JL; Deng F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of homeodomain-interacting protein kinase 2 promotes oral squamous cell carcinoma metastasis through inhibition of P53-dependent E-cadherin expression.
    Zheng X; Pan Y; Chen X; Xia S; Hu Y; Zhou Y; Zhang J
    Cancer Sci; 2021 Jan; 112(1):117-132. PubMed ID: 33063904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
    Lyu Q; Jin L; Yang X; Zhang F
    Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
    Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
    Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
    Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
    Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
    Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
    Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
    Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W
    Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.